Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04654507

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04654507
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Qatar (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04654507. Randomized; quadruple masking; primary purpose prevention. Start 2021-03-03 (actual); primary completion 2023-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children
Condition
Urinary Tract Infections in Children
Condition
Dexamethasone
Condition
Kidney Scarring
Condition
Acute Pyelonephritis
Condition
Hypertension in Children
Condition
Chronic Renal Failure
Condition
UTI
Intervention (Drug)
Dexamethasone Oral
Intervention (Drug)
Placebo
Lead sponsor
Hamad Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct04654507
Content hash
004573ea476b9f945b7790b9ca829a9418b35dbcd749a8821a7385aa0a2e3091